Trials / Completed
CompletedNCT01940146
Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 222 (actual)
- Sponsor
- Sun Pharma Advanced Research Company Limited · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study will assess the efficacy and safety of SPARC1310 when compared to placebo and active control
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPARC Placebo | Placebo |
| DRUG | SPARC1310 I | SPARC1310 I |
| DRUG | SPARC1310 II | SPARC1310 II |
| DRUG | SPARC1310 III | SPARC1310 III |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2013-09-12
- Last updated
- 2019-05-03
- Results posted
- 2016-04-11
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01940146. Inclusion in this directory is not an endorsement.